These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 23220021)
1. In-silico drug screening and potential target identification for hepatocellular carcinoma using Support Vector Machines based on drug screening result. Yang WL; Lee YE; Chen MH; Chao KM; Huang CY Gene; 2013 Apr; 518(1):201-8. PubMed ID: 23220021 [TBL] [Abstract][Full Text] [Related]
2. Using computational strategies to predict potential drugs for nasopharyngeal carcinoma. Lan MY; Yang WL; Lin KT; Lin JC; Shann YJ; Ho CY; Huang CY Head Neck; 2014 Oct; 36(10):1398-407. PubMed ID: 24038431 [TBL] [Abstract][Full Text] [Related]
3. Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures. Braconi C; Meng F; Swenson E; Khrapenko L; Huang N; Patel T Cancer; 2009 Aug; 115(16):3738-48. PubMed ID: 19514085 [TBL] [Abstract][Full Text] [Related]
4. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340 [TBL] [Abstract][Full Text] [Related]
5. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells. Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Xu Y; Xia F; Ma L; Shan J; Shen J; Yang Z; Liu J; Cui Y; Bian X; Bie P; Qian C Cancer Lett; 2011 Nov; 310(2):160-9. PubMed ID: 21802841 [TBL] [Abstract][Full Text] [Related]
8. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846 [TBL] [Abstract][Full Text] [Related]
9. Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma. Chen MH; Lin KJ; Yang WL; Kao YW; Chen TW; Chao SC; Chang PM; Liu CY; Tzeng CH; Chao Y; Chen MH; Yeh CN; Huang CY Cancer; 2013 Jan; 119(2):293-303. PubMed ID: 22810956 [TBL] [Abstract][Full Text] [Related]
10. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells. Tak E; Lee S; Lee J; Rashid MA; Kim YW; Park JH; Park WS; Shokat KM; Ha J; Kim SS J Hepatol; 2011 Feb; 54(2):328-39. PubMed ID: 21056497 [TBL] [Abstract][Full Text] [Related]
11. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Nam SW; Park JY; Ramasamy A; Shevade S; Islam A; Long PM; Park CK; Park SE; Kim SY; Lee SH; Park WS; Yoo NJ; Liu ET; Miller LD; Lee JY Hepatology; 2005 Oct; 42(4):809-18. PubMed ID: 16175600 [TBL] [Abstract][Full Text] [Related]
12. Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma. Miao J; Chen GG; Chun SY; Chak EC; Lai PB Int J Oncol; 2004 Sep; 25(3):651-9. PubMed ID: 15289866 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response. Caruso S; Calatayud AL; Pilet J; La Bella T; Rekik S; Imbeaud S; Letouzé E; Meunier L; Bayard Q; Rohr-Udilova N; Péneau C; Grasl-Kraupp B; de Koning L; Ouine B; Bioulac-Sage P; Couchy G; Calderaro J; Nault JC; Zucman-Rossi J; Rebouissou S Gastroenterology; 2019 Sep; 157(3):760-776. PubMed ID: 31063779 [TBL] [Abstract][Full Text] [Related]
14. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells. Jung EU; Yoon JH; Lee YJ; Lee JH; Kim BH; Yu SJ; Myung SJ; Kim YJ; Lee HS Cancer Lett; 2010 Dec; 298(1):9-15. PubMed ID: 20573444 [TBL] [Abstract][Full Text] [Related]
16. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637 [TBL] [Abstract][Full Text] [Related]